Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease

Molecular Genetics and Metabolism

Volumn 89, Issue 1-2, 2006, Pages 134-138

  Kroll, Charles A ^a   Ferber, Matt J ^a   Dawson, Brian D ^a   Jacobson, Robert M ^a   Mensink, Kara A ^a   Lorey, Fred ^b   Sherwin, John ^b   Cunningham, George ^b   Rinaldo, Piero ^a   Matern, Dietrich ^a   Hahn, Si Houn ^a  

^a Mayo Clinic College of Medicine   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Ceruloplasmin; Dried blood spots; ELISA; Newborn screening; Pediatric screening; Wilson disease

Indexed keywords

CERULOPLASMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; HUMAN; NEWBORN SCREENING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; CATION TRANSPORT PROTEINS; CERULOPLASMIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; INFANT; MALE; MASS SCREENING; RETROSPECTIVE STUDIES;

EID: 33747022446     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.03.008     Document Type: Article

References (20)

1. Yamaguchi Y., Heiny M.E., and Gitlin J.D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem. Biophys. Res. Commun. 197 (1993) 271-277
2. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., and Cox D.W. The Wilson gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5 (1993) 327-337
3. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., Romano D.M., Parano E., Pavone L., Brzustowicz L.M., Devoto M., Peppercorn J., Bush A.I., Sternlieb I., Pirastu M., Gusella J.F., Evgrafov O., Penchaszadeh G.K., Honig B., Edelman I.S., Soares M.B., Scheinberg I.H., and Gilliam T.C. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat. Genet. 5 (1993) 344-350
4. Ala A., and Schilsky M. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin. Liver Dis. 8 (2004) 787-805
5. Ala A., Borjigin J., Rochwarger A., and Schilsky M. Wilson disease in Septuagenarian siblings: Raising the bar for diagnosis. Hepatology 41 (2005) 668-670
6. Perri R., Hahn S.H., Ferber M., and Kamath P. Wilson disease-keeping the bar for diagnosis raised. Hepatology 42 (2005) 974
7. Dhawan A., Taylor R.M., Cheeseman P., De Silva P., Katsiyiannakis L., and Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplatation. Liver Transpl. 11 (2005) 441-448
8. Marcelli M., DiCiommo V., Callea F., DeVito R., Comparcola D., Sartorelli M.R., Carelli F., and Nobili V. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J. Lab. Clin. Med. 145 (2005) 139-143
9. Hahn S.H., Lee S.Y., Jang Y.J., Kim S.N., Shin H.C., Park S.Y., Han H.S., Yu E.S., Yoo H.W., Lee J.S., Chung C.S., Lee S.Y., and Lee D.H. Pilot study of mass screening for Wilson's disease in Korea. Mol. Genet. Metab. 76 (2002) 133-136
10. Ohura T., Abukawa D., Shiraishi H., Yamaguchi A., Arashima S., Hiyamuta S., Tada K., and Iinuma K. Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics. J. Inher. Metab. Dis. 22 (1999) 74-80
11. Endo F., Taketa K., Nakamura K., Awata H., Tanoue A., Eda Y., and Matsuda I. Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease. J. Inher. Metab. Dis. 17 (1994) 616-620
12. Yamaguchi Y., Aoki T., Arashima S., Ooura T., Takada G., Kitagawa T., Shigematsu Y., Shimada M., Kobayashi M., Itou M., and Endo F. Mass screening for Wilson's disease: results and recommendations. Pediatr. Int. 41 (1999) 405-408
13. Lovicu M.V., Dessi V., Zappu A., De Virgiliis A., Cao A., and Loudianos G. Efficient strategy for molecular diagnosis of Wilson disease in the sardinian population. Clin. Chem. 49 (2003) 496-498
14. Dedoussis G.V., Genschel J., Sialvera T.E., Bochow B., Manolaki N., Manios Y., Tsafantakis E., and Schmidt H. Wilson disease: high prevalence in a mountainous area of Crete. Ann. Hum. Genet. 69 (2005) 268-274
15. University of Alberta [homepage on the Internet]. Department of Medical Genetics: HUGO Wilson disease mutation database. Available at: http://www.medicalgenetics.med.ualberta.ca/wilson/index.php. Accessibility verified January 17, 2006.
16. Shah A.B., Chernov I., Zhang H.T., Ross B.M., Das K., Lutsenko S., Parano E., Pavone L., Evgrafov O., Ivanova-Smolenskaya I.A., Anneren G., Westermark K., Urrutia F.H., Penchaszadeh G.K., Sternlieb I., Scheinberg I.H., Gilliam T.C., and Petrukhin K. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am. J. Hum. Genet. 61 (1997) 317-328
17. Kim E.K., Yoo O.J., Song K.Y., Yoo H.W., Choi S.Y., Cho S.W., and Hahn S.H. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum. Mutat. 11 (1998) 275-278
18. Schulze A., Lindner M., Kohlmuller D., Olgemoller K., Mayatepek E., and Hoffmann G.F. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111 (2003) 1399-1406
19. Walshe J. Diagnostic significance of reduced serum ceruloplasmin concentration in neurological disease. Movement Disorders 20 (2005) 1658-1661
20. Macintyre G., Gutfreund K.S., Martin W.R., Camicioli R., and Cox D.W. Value of an enzymatic assay for the determination of serum ceruloplasmin. J. Lab. Clin. Med. 144 (2004) 294-301